SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 351 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $826 | +3.9% | 6,815 | +11.1% | 0.07% | -28.3% |
| Q4 2022 | $795 | -99.9% | 6,134 | -15.6% | 0.10% | -7.5% |
| Q3 2022 | $804,000 | +132.4% | 7,270 | +57.5% | 0.11% | +105.8% |
| Q2 2022 | $346,000 | -24.1% | 4,617 | -20.8% | 0.05% | -14.8% |
| Q1 2022 | $456,000 | -37.0% | 5,832 | -27.4% | 0.06% | -33.0% |
| Q4 2021 | $724,000 | +173.2% | 8,037 | +136.2% | 0.09% | +203.3% |
| Q2 2021 | $265,000 | +2.3% | 3,403 | +123.9% | 0.03% | -28.6% |
| Q4 2020 | $259,000 | -41.4% | 1,520 | -51.7% | 0.04% | -43.2% |
| Q3 2020 | $442,000 | -15.6% | 3,144 | -54.8% | 0.07% | +4.2% |
| Q3 2019 | $524,000 | +69.0% | 6,961 | +168.0% | 0.07% | +129.0% |
| Q1 2019 | $310,000 | +54.2% | 2,597 | -58.4% | 0.03% | +210.0% |
| Q3 2015 | $201,000 | – | 6,245 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |